| TP53 |
TP53, P53: Cellular tumor antigen p53 |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
0.475 |
Evidence |
|
| GAPD |
GAPDH, GAPD, CDABP0047, OK/SW-cl.12: Glyceraldehyde-3-phosphate dehydrogenase |
DNAJA1 |
DNAJA1, DNAJ2, HDJ2, HSJ2, HSPF4: DnaJ homolog subfamily A member 1 |
0.475 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
0.475 |
Evidence |
|
| EDD1 |
EDD1, EDD, HYD, KIAA0896: E3 ubiquitin-protein ligase EDD1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
0.475 |
Evidence |
|
| PFKFB2 |
PFKFB2: 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
CDC23 |
CDC23: Cell division cycle protein 23 homolog |
0.475 |
Evidence |
|
| CDC34 |
CDC34, UBE2R1: Ubiquitin-conjugating enzyme E2 R1 |
UBE2G1 |
UBE2G1, UBE2G: Ubiquitin-conjugating enzyme E2 G1 |
0.472 |
Evidence |
|
| CDH22 |
CDH22, C20orf25: Cadherin-22 precursor |
APC2 |
APC2, APCL: Adenomatous polyposis coli protein 2 |
0.472 |
Evidence |
|
| IRAK4 |
IRAK4: Interleukin-1 receptor-associated kinase 4 |
MYD88 |
|
0.472 |
Evidence |
O
|
| IFIH1 |
IFIH1, MDA5, RH116: Interferon-induced helicase C domain-containing protein 1 |
CARD8 |
CARD8, KIAA0955, NDPP1: Caspase recruitment domain-containing protein 8 |
0.472 |
Evidence |
|
| KIFAP3 |
KIFAP3, SMAP: Kinesin-associated protein 3 |
CDH10 |
CDH10: Cadherin-10 precursor |
0.472 |
Evidence |
|
| KIFAP3 |
KIFAP3, SMAP: Kinesin-associated protein 3 |
PCDHGB4 |
IPI00028619 |
0.472 |
Evidence |
|
| TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
IFIH1 |
IFIH1, MDA5, RH116: Interferon-induced helicase C domain-containing protein 1 |
0.472 |
Evidence |
|
| BIRC2 |
BIRC2, API1, IAP2, MIHB, RNF48: Baculoviral IAP repeat-containing protein 2 |
IFIH1 |
IFIH1, MDA5, RH116: Interferon-induced helicase C domain-containing protein 1 |
0.472 |
Evidence |
|
| FADD |
FADD, MORT1: Protein FADD |
QRICH1 |
IPI00328200 |
0.472 |
Evidence |
|
| TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
TNFRSF14 |
TNFRSF14, HVEA, UNQ329/PRO509, HVEM: Tumor necrosis factor receptor superfamily |
0.472 |
Evidence |
|
| CDH4 |
CDH4: Cadherin-4 precursor |
APC2 |
APC2, APCL: Adenomatous polyposis coli protein 2 |
0.472 |
Evidence |
|
| CDH4 |
CDH4: Cadherin-4 precursor |
CTNND2 |
CTNND2, NPRAP: Catenin delta-2 |
0.472 |
Evidence |
|
| F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
CXCL6 |
CXCL6, GCP2, SCYB6: Small-inducible cytokine B6 precursor |
0.472 |
Evidence |
|
| CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
TYRO3 |
TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor |
0.472 |
Evidence |
|
| GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
RAB9A |
RAB9, RAB9A: Ras-related protein Rab-9 |
0.472 |
Evidence |
O
|
| CASP4 |
CASP4, ICH2: Caspase-4 precursor |
IRAK3 |
IRAK3: Interleukin-1 receptor-associated kinase 3 |
0.472 |
Evidence |
|
| CASP4 |
CASP4, ICH2: Caspase-4 precursor |
IFIH1 |
IFIH1, MDA5, RH116: Interferon-induced helicase C domain-containing protein 1 |
0.472 |
Evidence |
|
| GDI1 |
GDI1, GDIL, OPHN2, RABGDIA, XAP4: Rab GDP dissociation inhibitor alpha |
RAB33A |
RAB33A, RABS10: Ras-related protein Rab-33A |
0.472 |
Evidence |
|
| ADORA1 |
ADORA1: Adenosine receptor A1 |
CX3CL1 |
CX3CL1, A-152E5.2, FKN, NTT, SCYD1: Fractalkine precursor |
0.472 |
Evidence |
|
| ADORA2B |
ADORA2B: Adenosine receptor A2b |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.472 |
Evidence |
|